Total Payments
$4,464
2023 Payments
$167.36
Companies
19
Transactions
261
Medicare Patients
513
Medicare Billing
$119,664
Payment Breakdown by Category
Food & Beverage$4,423 (99.1%)
Education$41.23 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,423 | 259 | 99.1% |
| Education | $41.23 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $797.16 | 68 | $0 (2023) |
| Allergan, Inc. | $791.27 | 30 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $711.90 | 47 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $638.04 | 39 | $0 (2021) |
| GlaxoSmithKline, LLC. | $232.04 | 2 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $223.35 | 15 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $214.98 | 13 | $0 (2021) |
| Shire North American Group Inc | $169.34 | 11 | $0 (2019) |
| Lundbeck LLC | $133.55 | 7 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $109.32 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $167.36 | 11 | Janssen Pharmaceuticals, Inc ($74.30) |
| 2022 | $307.71 | 16 | Janssen Pharmaceuticals, Inc ($120.75) |
| 2021 | $309.69 | 14 | GlaxoSmithKline, LLC. ($122.04) |
| 2020 | $369.04 | 26 | Allergan, Inc. ($158.46) |
| 2019 | $1,078 | 58 | Allergan Inc. ($452.62) |
| 2018 | $861.67 | 60 | Janssen Pharmaceuticals, Inc ($217.98) |
| 2017 | $1,370 | 76 | Sunovion Pharmaceuticals Inc. ($260.58) |
All Payment Transactions
261 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Neuroscience | ||||||
| 07/11/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Neurology | ||||||
| 06/21/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Neurology | ||||||
| 06/01/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Neuroscience | ||||||
| 05/24/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Neurology | ||||||
| 04/13/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Neuroscience | ||||||
| 03/16/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Neuroscience | ||||||
| 02/28/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Central Nervous System | ||||||
| 01/30/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Neuroscience | ||||||
| 01/04/2023 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Neurology | ||||||
| 11/22/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Central Nervous System | ||||||
| 11/03/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Neuroscience | ||||||
| 09/28/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Neuroscience | ||||||
| 09/15/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Neuroscience | ||||||
| 08/30/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: CNS | ||||||
| 08/04/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Central Nervous System | ||||||
| 07/19/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Neuroscience | ||||||
| 07/14/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Central Nervous System | ||||||
| 06/16/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Neuroscience | ||||||
| 05/17/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: VACCINES | ||||||
| 05/17/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: Neuroscience | ||||||
| 03/31/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/23/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: Neuroscience | ||||||
| 03/01/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 91 | 217 | $34,680 | $15,605 |
| 2022 | 3 | 141 | 510 | $82,040 | $36,141 |
| 2021 | 3 | 126 | 556 | $90,040 | $39,539 |
| 2020 | 4 | 155 | 510 | $77,030 | $28,379 |
Total Patients
513
Total Services
1,793
Medicare Billing
$119,664
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 73 | 199 | $23,880 | $12,590 | 52.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 18 | 18 | $10,800 | $3,015 | 27.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 81 | 331 | $40,200 | $19,794 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 149 | $23,840 | $11,177 | 46.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 30 | 30 | $18,000 | $5,170 | 28.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 58 | 325 | $39,000 | $18,711 | 48.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 199 | $31,840 | $15,389 | 48.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 32 | 32 | $19,200 | $5,439 | 28.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 242 | $38,720 | $14,511 | 37.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 64 | 202 | $24,240 | $9,348 | 38.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 32 | 51 | $5,070 | $2,452 | 48.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 15 | 15 | $9,000 | $2,069 | 23.0% |
About Dr. Daniel Sanchez, M.D
Dr. Daniel Sanchez, M.D is a Psychiatry healthcare provider based in West New York, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164482428.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Sanchez, M.D has received a total of $4,464 in payments from pharmaceutical and medical device companies, with $167.36 received in 2023. These payments were reported across 261 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,423).
As a Medicare-enrolled provider, Sanchez has provided services to 513 Medicare beneficiaries, totaling 1,793 services with total Medicare billing of $119,664. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location West New York, NJ
- Active Since 03/23/2006
- Last Updated 10/06/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164482428
Products in Payments
- LATUDA (Drug) $711.90
- ABILIFY MAINTENA (Drug) $505.29
- INVEGA SUSTENNA (Drug) $491.81
- VRAYLAR (Drug) $466.86
- REXULTI (Drug) $266.30
- INVEGA TRINZA (Drug) $250.23
- TEFLARO (Drug) $247.09
- INGREZZA (Drug) $214.98
- VYVANSE (Drug) $140.67
- AUSTEDO (Drug) $131.92
- BEXSERO (Biological) $122.04
- DALVANCE (Drug) $119.70
- SHINGRIX (Biological) $110.00
- NUEDEXTA (Drug) $109.32
- Tresiba (Drug) $93.96
- Aristada 441 mg (Drug) $71.53
- Fanapt (Drug) $64.42
- SPRAVATO (Drug) $55.12
- CAPLYTA (Drug) $48.25
- SD809-TD (Drug) $45.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.